Clinical trial
A Randomized Placebo-controlled Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Study
NCT04562831 is registered in ClinicalTrials.gov with Haukeland University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Placebo-controlled Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Study
- Lead sponsor
- Haukeland University Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 7, 2020
- Completion date
- October 31, 2027
- Enrollment
- 380 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.